Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Fostroxacitabine bralpamide hydrochloride by Medivir for Hepatocellular Carcinoma: Likelihood of Approval
Fostroxacitabine bralpamide hydrochloride is under clinical development by Medivir and currently in Phase II for Hepatocellular Carcinoma. According to GlobalData,...